SCHEMBL7966614

SCHEMBL7966614

CC(C)c1cc(/C=C(\C#N)S(=O)(=O)c2ccc(C(F)(F)F)cc2)cc(C(C)C)c1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.45
HPGD P15428 5/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
ALDH1A1 P00352 4/20 0.44
PKM P14618 3/20 0.44
KMT2A Q03164 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
KDM4E B2RXH2 2/20 0.44
HSD17B10 Q99714 2/20 0.44
MEN1 O00255 2/20 0.44
POLB P06746 1/20 0.44
GAA P10253 1/20 0.44
ALPG P10696 1/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
MAPT P10636 3/20 0.37
KDR P35968 1/20 0.37
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7966617 1.00 EGFR (0.45) EGFRHPGDSMN1; SMN2ALDH1A1PKM
SCHEMBL7966616 1.00 EGFR (0.45) EGFRHPGDSMN1; SMN2ALDH1A1PKM
SCHEMBL7967172 0.88 SMN1; SMN2 (0.44) EGFRHPGDSMN1; SMN2ALDH1A1PKM
SCHEMBL7967179 0.88 SMN1; SMN2 (0.44) EGFRHPGDSMN1; SMN2ALDH1A1PKM
SCHEMBL7967176 0.88 SMN1; SMN2 (0.44) EGFRHPGDSMN1; SMN2ALDH1A1PKM
SCHEMBL7963152 0.87 PKM (0.57) EGFRHPGDSMN1; SMN2ALDH1A1PKM
SCHEMBL7963145 0.87 PKM (0.57) EGFRHPGDSMN1; SMN2ALDH1A1PKM
SCHEMBL7963148 0.87 PKM (0.57) EGFRHPGDSMN1; SMN2ALDH1A1PKM
SCHEMBL4075770 0.86 PKM (0.47) EGFRHPGDSMN1; SMN2ALDH1A1PKM
SCHEMBL4077025 0.86 PKM (0.47) EGFRHPGDSMN1; SMN2ALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US claimed
US-6225346-B1 FOR THERAPY AND PROPHYLAXIS OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. 2001-05-01 US disclosed
US-5935993-A TYROSINE KINASE INHIBITORS; TREATMENT OF CELL GROWTH, CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1999-08-10 US disclosed
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US disclosed